©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 107626
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.107626
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.107626
Table 4 Risk factors influencing the prognosis of esophageal cancer patients
| Independent variable | β value | SE value | Wald χ2 value | OR | 95%CI | P value |
| Age | 1.341 | 0.614 | 4.770 | 3.823 | 1.147-12.736 | 0.030 |
| Differentiation degree | 1.569 | 0.712 | 4.856 | 4.802 | 1.189-19.385 | 0.028 |
| AJCC clinical staging | 1.317 | 0.528 | 6.222 | 3.732 | 1.326-10.505 | 0.013 |
| AFP | 1.255 | 0.527 | 5.671 | 3.508 | 1.249-9.854 | 0.018 |
| TSP-1 | 1.749 | 0.638 | 7.515 | 5.749 | 1.646-20.075 | 0.006 |
| CEA | 1.354 | 0.622 | 4.739 | 3.873 | 1.144-13.107 | 0.030 |
| Sarcopenia | 1.279 | 0.533 | 5.758 | 3.593 | 1.264-10.213 | 0.017 |
- Citation: Wang DE, Qin XF, Yang W. Correlation between sarcopenia diagnosed by C3SMI criteria and prognosis in esophageal cancer patients after radiotherapy. World J Gastrointest Oncol 2025; 17(9): 107626
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/107626.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.107626